LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB (Q24338913)

CDK5 regulatory subunit associated protein 3

1 reference

Histone deacetylase 3

1 reference

histone deacetylase 1

1 reference

RELA proto-oncogene, NF-kB subunit

1 reference

NF-kappaB binding

1 reference

5

Wendell G Yarbrough

0 references

author name string

Jialiang Wang

1

0 references

Hanbing An

2

0 references

Marty W Mayo

3

0 references

Albert S Baldwin

Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway

4

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Cancer Cell

0 references

volume

12

0 references

issue

3

0 references

page(s)

239-51

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

A genetic screen for candidate tumor suppressors identifies REST

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Shaping the nuclear action of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

NF-kappaB and IKK as therapeutic targets in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

The human papillomavirus E6 protein and its contribution to malignant progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Regulation of NF-kappaB by atypical activators and tumour suppressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Endogenous inhibitors of nuclear factor-kB, an opportunity for cancer control

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Matrix metalloproteinases: roles in cancer and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021

Targeting retinoblastoma protein for degradation by proteasomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2007.07.002

7 January 2021